focus -WSS

focus

author：knowledge 2025-09-03 09:26:22 - browse：6

Pascal Soriot - Senate Finance Committee — AstraZeneca CEO Pascal Soriot Jacquelyn Martin/AP

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly.

Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals. On Thursday, at a press briefing at which they presented their 2023 earnings, AstraZeneca executives also played coy about the bargaining over the price of the company’s diabetes drug Farxiga.

“We have received the first offer, but as you can imagine, we will not disclose what the offer is,” Ruud Dobber, the company’s executive vice president of biopharmaceuticals business, said at the event, held at the London Stock Exchange. “We are in active negotiation, and it will be a few rounds of discussions” with Medicare.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： STAT Madness 2024: Meet the contenders

focus

WSS

Blinken talks high

NEJM study measures Covid brain fog, impact on IQ

How are insurers handling Leqembi and related scans?

A Greenpeace activist is fined for crash

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Antibody drugs appear effective. Now can we make enough of them?

focus

focus

hotspot

In age of alternative facts, a scholarly course on calling out crap

How are insurers handling Leqembi and related scans?

In age of alternative facts, a scholarly course on calling out crap

Elisabeth Bik tackles the widespread issue of research misconduct

How to save PrEP access — and even expand it

STAT Madness 2024: Meet the contenders

Tori Bowie and the unacceptable rates of Black maternal death

Change Healthcare cyberattack shows risk of industry consolidation

Bright Health sells Medicare Advantage business to Molina

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

leisure time

The debate over Covid

Using force crossed my mind when examining a defiant young patient

Digital health funding stays low as a new reality sets in

Elisabeth Bik tackles the widespread issue of research misconduct

Vermont grapples with historic flooding as more rainstorms head for Northeast

Cuban government calls US nuclear submarine stop a 'provocative escalation'

entertainment

focus

focus

Wikipedia